The P2X3 subunit: a molecular target in pain therapeutics.
P2X receptors are hetero-oligomeric proteins that function as membrane ion channels and are gated by extracellular ATP. The P2X3 subunit is a constituent of the channels on a subset of sensory neurons involved in pain signaling, where ATP released by damaged and inflamed tissue can initiate action potentials. The tissue distribution of this subunit, along with experiments using antagonists, antisense oligonucleotides and gene knockouts, suggests that it may be a useful target for the development of pain therapeutics. This has been substantiated by the development by Abbott of a small molecule that selectively blocks P2X3 subunit-containing P2X receptors, and which is effective in a range of animal models of neuropathic and chronic inflammatory pain.[1]References
- The P2X3 subunit: a molecular target in pain therapeutics. North, R.A. Current opinion in investigational drugs (London, England : 2000) (2003) [Pubmed]
Annotations and hyperlinks in this abstract are from individual authors of WikiGenes or automatically generated by the WikiGenes Data Mining Engine. The abstract is from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.About WikiGenesOpen Access LicencePrivacy PolicyTerms of Useapsburg
